BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 23, 2005
View Archived Issues
Pharmexa files to start second phase II HER-2 Protein AutoVac study
Read More
NLA Nasal Spray shows rapid relief after histamine challenge
Read More
Schering-Plough completes acquisition of most NeoGenesis assets
Read More
VIGIV approved to treat complications of smallpox vaccination
Read More
Novartis to acquire generics players Hexal and Eon Labs
Read More
Henry Ford Hospital studies Viagra for stroke recovery
Read More
Spectrum acquires exclusive license to endothelin B agonists for cancer
Read More
Ammonul approved for urea cycle disorder
Read More
Biosite launches Triage D-Dimer Test
Read More
Triage Stroke Panel PMA accepted for review
Read More
Bavarian Nordic invests in smallpox vaccine production, product development
Read More
Excellent pharmacokinetic profile of antitubercular drug SQ-109
Read More
Rasagiline treatment benefits levodopa-treated Parkinson's disease patients
Read More
XP-828L reported to improve the symptoms of chronic plaque psoriasis
Read More
IDEA-070 reported better than hydrocortisone-21-acetate in UV-induced sunburn
Read More
Tamoxifen reduces myocardial infarction, angina
Read More
Update on bevacizumab in colorectal cancer
Read More
Prialt approved in Europe
Read More
Approvable letter for Surfaxin
Read More
European approval for Azilect
Read More
Prostaglandin D2 (DP) receptor antagonists disclosed by Merck Frosst
Read More
Glenmark presents novel PDE4 inhibitors for inflammatory and allergic conditions
Read More
The use of novel beta-secretase inhibitors for Alzheimer's disease claimed by GSK
Read More
Hadasit researchers disclose a uPA-derived octapeptide for the treatment of MS
Read More
AEgera discovers new agents for the treatment of cancer and neuronal disorders
Read More